Article metrics

Original research
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2021

AbstractFullPdf
Jul 2021464468135
Aug 2021287288137
Sep 202121621688
Total967972360